George Ansstas

12PUBLICATIONS
73CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 01, 2026
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Feb 26, 2026
Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial.

Jian L Campian, Son B Le, Ashley Ghiaseddin

|Feb 03, 2026
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

George Ansstas, Karam Khaddour, Sumedha Sudhaman

|Jan 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort.

George Nassief, Tolulope Adeyelu, Andrew Elliott

|Sep 28, 2024
Recent Advancements in Cell-Based Therapies in Melanoma.

George Nassief, Angela Anaeme, Karen Moussa

Pageof 2

Frequent Collaborators

4 joint publications

George Nassief

3 joint publications

Karam Khaddour

3 joint publications

Jiayi Huang

2 joint publications

Milan G Chheda